Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets.
作者信息
Jakeman K J, Tisdale M, Russell S, Leone A, Sweet C
机构信息
School of Biological Sciences, Microbial Molecular Genetics and Cell Biology Research Group, University of Birmingham, United Kingdom.
出版信息
Antimicrob Agents Chemother. 1994 Aug;38(8):1864-7. doi: 10.1128/AAC.38.8.1864.
Abstract
Single-dose treatments (5 to 40 mg/kg of body weight given intraperitoneally) of ferrets with 2'-deoxy-2'-fluoroguanosine or its prodrug, 2,6-diamino-purine-2'-fluororiboside, 1 h after infection with influenza A virus significantly inhibited replication of virus in the upper respiratory tract, resulting in amelioration of fever and nasal inflammation. Replication of virus in the lower respiratory tract was also reduced > 100-fold, but three doses were required to prevent replication in the lungs. In ferrets infected with influenza B virus, single-dose treatment (40 mg/kg given intraperitoneally) produced a similar but reduced response in comparison with that in ferrets infected with influenza A virus, indicating that dosing was not optimal for this virus.
摘要
相似文献
1
Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets.
Antimicrob Agents Chemother. 1994 Aug;38(8):1864-7. doi: 10.1128/AAC.38.8.1864.
2
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
Antimicrob Agents Chemother. 1998 Mar;42(3):640-6. doi: 10.1128/AAC.42.3.640.
3
Comparative anti-influenza virus activity of 2'-deoxy-2'-fluororibosides in vitro.
Antiviral Res. 1993 Aug;21(4):357-68. doi: 10.1016/0166-3542(93)90013-9.
4
Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
Antivir Ther. 2018;23(4):295-306. doi: 10.3851/IMP3135.
5
Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model.
Transl Res. 2020 Apr;218:16-28. doi: 10.1016/j.trsl.2019.12.002. Epub 2019 Dec 25.
6
GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is a potent inhibitor of influenza virus in ferrets.
Antimicrob Agents Chemother. 1995 Nov;39(11):2583-4. doi: 10.1128/AAC.39.11.2583.
7
Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine.
Antimicrob Agents Chemother. 1995 Nov;39(11):2454-8. doi: 10.1128/AAC.39.11.2454.
8
[Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Vopr Virusol. 2010 May-Jun;55(3):19-27.
9
Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.
Antimicrob Agents Chemother. 2011 Nov;55(11):4961-70. doi: 10.1128/AAC.00412-11. Epub 2011 Aug 15.
10
CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.
Antimicrob Agents Chemother. 2009 Jan;53(1):186-92. doi: 10.1128/AAC.00333-08. Epub 2008 Oct 27.
引用本文的文献
1
Advances and Challenges in Antiviral Development for Respiratory Viruses.
Pathogens. 2024 Dec 31;14(1):20. doi: 10.3390/pathogens14010020.
2
Silver ions blocking crystallization of guanosine-based hydrogel for potential antimicrobial applications.
RSC Adv. 2018 Apr 27;8(28):15842-15852. doi: 10.1039/c8ra02500b. eCollection 2018 Apr 23.
3
Influenza antivirals and animal models.
FEBS Open Bio. 2022 Jun;12(6):1142-1165. doi: 10.1002/2211-5463.13416. Epub 2022 Apr 27.
4
The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development.
Viruses. 2021 Apr 15;13(4):678. doi: 10.3390/v13040678.
5
Nucleosides for the treatment of respiratory RNA virus infections.
Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618764483. doi: 10.1177/2040206618764483.
6
Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs.
PLoS One. 2017 Oct 11;12(10):e0185998. doi: 10.1371/journal.pone.0185998. eCollection 2017.
7
Secondary Bacterial Infections Associated with Influenza Pandemics.
Front Microbiol. 2017 Jun 23;8:1041. doi: 10.3389/fmicb.2017.01041. eCollection 2017.
8
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.
Med Res Rev. 2016 Nov;36(6):1127-1173. doi: 10.1002/med.21401. Epub 2016 Aug 29.
9
Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.
PLoS One. 2016 Jul 28;11(7):e0159847. doi: 10.1371/journal.pone.0159847. eCollection 2016.
10
Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets.
PLoS One. 2011;6(11):e27512. doi: 10.1371/journal.pone.0027512. Epub 2011 Nov 16.
本文引用的文献
1
Genetic composition and virulence of influenza virus: differences in facets of virulence in ferrets between two pairs of recombinants with RNA segments of the same parental origin.
J Gen Virol. 1982 Feb;58(Pt 2):387-98. doi: 10.1099/0022-1317-58-2-387.
2
Human influenza resulting from aerosol inhalation.
Proc Soc Exp Biol Med. 1966 Jul;122(3):800-4. doi: 10.3181/00379727-122-31255.
3
Quantitative studies on the tissue localization of influenza virus in ferrets after intranasal and intravenous or intracardial inoculation.
Br J Exp Pathol. 1969 Dec;50(6):612-8.
4
The behaviour of antigenically related influenza viruses of differing virulence on disulphide-linked immunosorbents.
Immunochemistry. 1974 Dec;11(12):823-6. doi: 10.1016/0019-2791(74)90304-8.
5
Purification of influenza viruses using disulphide-linked immunosorbents derived from rabbit antibody.
Immunochemistry. 1974 Jun;11(6):295-304. doi: 10.1016/0019-2791(74)90365-6.
6
Lessons for human influenza from pathogenicity studies with ferrets.
Rev Infect Dis. 1988 Jan-Feb;10(1):56-75. doi: 10.1093/clinids/10.1.56.
7
Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins.
J Gen Virol. 1989 Jun;70 ( Pt 6):1523-31. doi: 10.1099/0022-1317-70-6-1523.
8
Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets.
J Infect Dis. 1991 Nov;164(5):969-72. doi: 10.1093/infdis/164.5.969.
9
The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man.
Br J Exp Pathol. 1976 Feb;57(1):37-48.
10
The relation of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence.
Br J Exp Pathol. 1977 Aug;58(4):444-58.
Zotero 插件